Regulatory Beat

Apr 01, 2013
BioPharm International
Opioid abuse generates calls for efforts to curb distribution.
Mar 01, 2013
BioPharm International
Vaccine development is benefiting from manufacturing advances.
Feb 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Jan 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Dec 01, 2012
BioPharm International
White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
Nov 01, 2012
BioPharm International
Manufacturing and in-depth characterization provide basis for demonstrating product equivalence.
Oct 01, 2012
BioPharm International
User fees aim to speed approvals and support inspections.
Sep 01, 2012
BioPharm International
Manufacturers and regulators struggle to control phony versions of crucial medicines.
native1_300x100
lorem ipsum